Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. KYMR
KYMR logo

KYMR News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

KYMR News

Analysis of XBI ETF's 52-Week Price Fluctuations

5d agoNASDAQ.COM

Kymera Completes Enrollment in Phase 2b Trial Ahead of Schedule

Jun 27 2026NASDAQ.COM

Kymera Therapeutics Completes Enrollment Early in Key Clinical Trial

Jun 26 2026Fool

Bio-Techne Soars Over 20% on Merck Acquisition News

Jun 26 2026NASDAQ.COM

Kymera Accelerates Clinical Trial Timeline for KT-621

Jun 26 2026stocktwits

Biotech Stocks Surge Amid Positive Trials and Earnings

Jun 25 2026CNBC

Kymera Accelerates KT-621 Trial Data Timeline

Jun 25 2026seekingalpha

Kymera Therapeutics Completes BROADEN2 Trial Enrollment Ahead of Schedule

Jun 25 2026Newsfilter

KYMR Events

No data

No data

KYMR Monitor News

Kymera Therapeutics Completes BROADEN2 Trial Enrollment Ahead of Schedule

Jun 25 2026

Kymera Therapeutics stock rises despite market decline

Jun 22 2026

Kymera Therapeutics Reports Strong Q4 Progress and New Partnerships

Feb 26 2026

Kymera Therapeutics Hits 52-Week High on KT-621 Trial Results

Dec 08 2025

KYMR Earnings Analysis

No Data

No Data

People Also Watch